Three-dimensional matrix suppresses E2F-controlled gene expression in glomerular mesangial cells

Kidney International

Volumn 57, Issue 4, 2000, Pages 1581-1589

  Tsuboi, Nobuo ^a,b   Yoshida, Hiroaki ^a,b   Kawamura, Tetsuya ^a,b   Furukawa, Yusuke ^a,b   Hosoya, Tatsuo ^a,b   Yamada, Hisashi ^a,b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

E2F; Extracellular matrix; Mesangial cell; Phenotype; Retinoblastoma family proteins

Indexed keywords

CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MESANGIUM; PRIORITY JOURNAL;

EID: 0034112568     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00002.x     Document Type: Conference Paper

References (48)

1. 1. ABBOUD HE: Growth factors in glomerulonephritis. Kidney Int 43:252-267, 1989
2. 2. STRIKER LJ, DOI T, ELLIOT S, STRIKER GE: The contribution of glomerular cells to progressive glomerulonephritis. Semin Nephrol 9:318-328, 1989
3. 3. BURRIDGE K, CHRZANOWSKA-WODNICKA M: Focal adhesions, contractility, and signaling. Annu Rev Cell Biol 12:463-518, 1996
4. 4. JURIANO RL, HASKILL S: Signal transduction from the extracellular matrix. J Cell Biol 120:577-585, 1993
5. 5. PLOOPER GE, MCNAMEE HP, DIKI LE, BOJANOWSKI K, INGBER DE: Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Cell Biol 6:1349-1365, 1995
6. 6. KITAMURA M, ISHIKAWA Y: Three-dimensional matrix primes mesangial cells to down-regulation of α-smooth muscle actin via deactivation of CArG box elements. Kidney Int 53:690-697, 1998
7. 2 gene expression and tissue remodeling. J Cell Biol 140:709-719, 1998
8. 8. SIMOSON MS, CULP LA, DUNN MJ: Rat mesangial cell-matrix interactions in culture. Exp Cell Res 184:484-498, 1989
9. 9. KITAMURA M, MITARAI T, MARUYAMA N, NAGASAWA R, YOSHIDA H, SAKAI O: Mesangial cell behavior in a three-dimensional extracellular matrix. Kidney Int 4:653-661, 1991
10. 10. KITAMURA M, MITARAI T, NAGASAWA R, MARUYAMA N: Differentiated phenotype of glomerular mesangial cells in nodular culture. Am J Physiol 270:F614-F622, 1996
11. 11. PABST R, STERZH RB: Cell renewal of glomerular cell types in normal rats: An autoradiographic analysis. Kidney Int 24:626-631, 1983
12. 12. FLOEGF J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPER CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferate nephritis. Kidney Int 40:477-488, 1991
13. 13. FLOEGE J, ALPER CE, BURNES MW, PRITZL P, GORDON K, COUSER WG, JOHNSON RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 66:485-497, 1997
14. 14. BARICOS WH, SHAH SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 40:161-173, 1991
15. 15. LOVETT DH, JOHNSON RJ, MARTI H-P, MARTIN J, DAVIS M, COUSER WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98, 1992
16. 16. DYSON N: The regulation of E2F by pRB-family proteins. Genes Dev 12:2245-2262, 1998
17. 17. HIEBERI SW, LIPP M, NEVINS JR: E1 A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc Natl Acad Sci USA 86:3594-3598, 1989
18. 18. SYLVESTER AM, CHEN D, KRASINSKI K, ANDRES V: Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation. J Clin Invest 101:940-948, 1998
19. 19. DALTON S: Cell cycle regulation of the human cdc 2 gene. EMBO J 11:1797-1804, 1992
20. 20. JOHNSON DG: Regulation of E2F-1 gene expression by p130 (Rb2) and d-type cyclin kinase activity. Oncogene 11:1685-1692, 1995
21. 21. IWASE S, FURUKAWA Y, KIKUCHI J, NAGAI M, TERUI Y, NAKAMURA M, YAMADA H: Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J Biol Chem 272:12406-12414, 1997
22. 22. LI JM, HU PP, SHEN X, YU Y, WABG XF: E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor β through E2F binding sites. Proc Natl Acad Sci USA 94:4948-4953, 1997
23. 23. LEI HY, DOHI DF, KIM YH, WAISH GL, CONSOLI U, ANDREFF M, DAWSON MI, HONG WK, KURIE JM: All-trans retinoic acid converts E2F into a transcriptional suppresser and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway. J Clin Invest 101:1012-1019, 1998
24. 24. KAELIN WG, KREK W, SELLERS WR, DECAPRIO JA, AJCHENBAUM F, FUCHS CS, CHITTENDEN T, LEE Y, FARNHAM PJ, BLANAR MA, LIVINGSTONE DM, FLEMINGTON EK: Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364, 1992
25. 25. GINSBERG D, VAIRO G, CHITTENDEN T, XIAO Z-X, ZU G, WYDNER KL, DECAPRIO JA, LAWRENCE JB, LIVINGSTON DM: E2F-4, a new member of the E2F transcriptional factor family, interacts with p107. Genes Dev 8:2665-2679, 1994
26. 26. FURUKAWA Y, UENOYAMA S, OHIA M, TSUNODA A, GRIFFRIN JD, SAITO M: Transforming growth factor-beta inhibits phosphorylation of the retinoblasloma susceptibility gene product in human monocytic leukemia cell line JOSK-1. J Biol Chem 267:17121-17127, 1992
27. 27. BEIJERBERGEN RL, KERKHOVEN RM, ZHU L, CARLEE L, VOORHOEVE PM, BERNARDS R: E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p 107 in vivo. Genes Der 8:2680-2690, 1992
28. 28. VAIRO G, LIVINGSTON DM, GINSBERG D: Functional interaction between E2F-4 and p 130: Evidence for distinct mechanisms underling growth suppression by different retinoblastoma protein family members. Genes Dev 9:869-881, 1995
29. 29. LUNDBERG AS, WEINBERG RA: Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761, 1998
30. 30. FANG F, OREND G. WATANABE N, HUNTER T, RUOSLAHII E: Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science 271:499-502, 1996
31. 31. SCHULZE A, ZERFASS-THOME K, BERGES J, MIDDENDORP S, JANSEN-DURR P, HENGLEIN B: Anchorage-dependent transcription of the cyclin A gene. Mol Cell Biol 16:4632-4638, 1996
32. 32. ZHU X, OHTSUBO M, BOHMER RM, ROBERTS JM, ASSOIAN RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133:391-403, 1996
33. 33. WEINBERG RA: E2F and cell proliferation: A world turned upside down. Cell 85:457-459, 1996
34. 34. YAMASAKI L, JACKS T, BRONSON R, GOILLOT E, HARLOW E, DYSON NJ: Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-548, 1996
35. 35. WEINTRAUB SJ, CHOW KNB, LUO RX, ZHANG SH, HE S, DEAN DC: Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812-815, 1995
36. 36. SMITH EJ, LEONE G, NEVINS JR: Distinct mechanisms control the accumulation of the Rb-Related p107 and p130 proteins during cell growth. Cell Growth Differ 9:297-303, 1998
37. 37. MARX M, DORSCH O: pp60c-src is required for the induction of a quiescent mesangial cell phenotype. Kidney Int 51:110-118, 1997
38. 38. CORBEIL HB, WHYTE P, BRANTON PE: Characterization of transcription factor E2F complexes during muscle and neuronal differentiation. Oncogene 11:909-920, 1995
39. 39. RAMPALLI AM, GAO CY, CHAUIHAIWALE VM, ZELENSKA PS: pRb and p107 regulate E2F activity during lens fiber cell differentiation. Oncogene 16:399-408, 1998
40. 40. GU W, SCHNIDER JW, CONDORELLI G, KAUSHAL S, MAHDAVI V, NADAL-GINARD B: Interaction of myogenic factors and the retinoblastoma proteins mediates muscle cell commitment and differentiation. Cell 72:309-324, 1993
41. 41. CHEN PL, RILEY DJ, CHEN Y, LEE WH: Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc Natl Acad Sci USA 93:465-469, 1996
42. 42. CHEN PL, RILEY DJ, CHEN Y, LEE WH: Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10:2794-2804, 1996
43. 43. WARY KK, MAINIERO F, ISAKOFF SJ, MARCANTONIO EE, GIANCOTTI FG: The adaptor protein She couples a class of integrins to the control of cell cycle progression. Cell 87:733-743, 1996
44. 44. MIRALEM T, TEMPLETON DM: Inactivation of kinase cascades in mesangial cells grown on collagen type I. Am J Physiol 275:F585-F594, 1998
45. 45. KOYAMA H, RAINES EW, BORNFELDI KE, ROBERTS JM, Ross R: Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069-1078, 1996
46. 46. TOYOSHIMA H, HUNTER T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994
47. 47. MURPHY G, REYNOLDS JJ: Extracellular matrix degradation, in Connective Tissue and its Heritable Disorders, edited by ROYCE PM, SIEINMANN B, New York, Wiley-Liss Inc., 1993, pp 287-316
48. 48. SHANKLAND SJ: Cell-cycle control and renal disease. Kidney Int 52:294-308, 1997